Abiopharma

🔍 Matheis Dennis (Director)

Company: Lucid Diagnostics Inc. (LUCD)

Report Date: 2025-08-20

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Common Stock at $1.0184 per share (Direct)
  Date: 2025-08-20 | Code: P | equity_swap_involved: 0 | shares_owned_after: 665,443.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0085 to $1.0286. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.